Back to results
CompletedPhase 3

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

NCT01128894

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Birmingham, Alabama, United States

+172 additional locations

View on ClinicalTrials.gov